We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$274B
AUM Growth
+$5.82B
Cap. Flow
-$10.4B
Cap. Flow %
-3.8%
Top 10 Hldgs %
16.33%
Holding
11,664
New
983
Increased
3,964
Reduced
4,263
Closed
2,126

Sector Composition

Rank Sector Weight
1 Technology 12.29%
2 Financials 8.09%
3 Healthcare 6.75%
4 Consumer Discretionary 5.04%
5 Industrials 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTZG
9326
DELISTED
Nuveen Global Net Zero Transition ETF
NTZG
$27 ﹤0.01%
+1
New +$27
RGC icon
9327
Regencell Bioscience
RGC
$2.99B
$26 ﹤0.01%
38
-25,384
-100% -$18.7K
NAVB
9328
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$26 ﹤0.01%
100
MRM
9329
MEDIROM Healthcare Technologies
MRM
$7.19M
$25 ﹤0.01%
4
-1,935
-100% -$11.7K
BLEUR
9330
DELISTED
bleuacacia ltd Rights
BLEUR
$25 ﹤0.01%
800
+780
+3,900% +$57
ACER
9331
DELISTED
Acer Therapeutics Inc
ACER
$25 ﹤0.01%
33
-1,360
-98% -$2.68K
ZSPY
9332
DELISTED
ASYMmetric Smart Alpha S&P 500 ETF
ZSPY
$25 ﹤0.01%
+1
New +$24
FNCH
9333
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$25 ﹤0.01%
2
-5
-71% -$66
BRIVW
9334
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$24 ﹤0.01%
+360
New +$27
HIDE icon
9335
Alpha Architect High Inflation and Deflation ETF
HIDE
$145M
$23 ﹤0.01%
1
-673
-100% -$15.7K
SER icon
9336
Serina Therapeutics
SER
$32.1M
$23 ﹤0.01%
1
-383
-100% -$8.8K
NBSTW
9337
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$23 ﹤0.01%
500
-1,069
-68% -$68
TRTL.WS
9338
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$23 ﹤0.01%
226
-2,361
-91% -$429
HCWB icon
9339
HCW Biologics
HCWB
$5.75M
-2
Closed -$866
JRE icon
9340
Janus Henderson US Real Estate ETF
JRE
$4.18M
$22 ﹤0.01%
1
-1,316
-100% -$29.8K
ONYXW
9341
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$22 ﹤0.01%
200
-600
-75% -$58
CMCAW
9342
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$22 ﹤0.01%
406
+306
+306% +$21
MLPO
9343
DELISTED
Credit Suisse S&P MLP Index ETN
MLPO
$22 ﹤0.01%
2
-200
-99% -$2.67K
IVCAW
9344
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$21 ﹤0.01%
+300
New +$20
SLVRW
9345
DELISTED
SilverSPAC Inc. Warrant
SLVRW
$21 ﹤0.01%
100
-100
-50% -$17
AISPW
9346
Airship AI Holdings Warrants
AISPW
$13.5M
$20 ﹤0.01%
200
-600
-75% -$50
TCBPW
9347
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$20 ﹤0.01%
+200
New +$25
FAIL
9348
DELISTED
Cambria Global Tail Risk ETF
FAIL
$20 ﹤0.01%
1
-169
-99% -$3.35K
SEPAW
9349
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$20 ﹤0.01%
+495
New +$30
GAQ.WS
9350
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$20 ﹤0.01%
+139
New +$20

Similar funds

UBS Group's Q1 2023 Portfolio in Review

As of Q1 2023, UBS Group held 11,664 positions worth $274B, up 2.2% from $268B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $10.4B in Q1 2023, closing 2,126 positions and reducing 4,263 holdings. Its most notable exit was LHC Group LLC, an estimated $49M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in First Trust Nasdaq Oil & Gas ETF worth $13.3M.

  • UBS Group's largest Q1 2023 buy was First Trust Nasdaq Oil & Gas ETF: 493,205 shares worth $13.3M.
  • UBS Group added most to UBS Group in Q1 2023, an estimated $3.78B increase.
  • UBS Group's biggest Q1 2023 reduction was Microsoft, cutting an estimated $820M.
  • UBS Group fully exited LHC Group LLC in Q1 2023, selling an estimated $49M.
  • UBS Group's ten largest holdings make up 16% of its $274B portfolio in Q1 2023.
  • UBS Group opened 983 new positions and closed 2,126 in Q1 2023.
  • UBS Group's portfolio value rose 2.2% quarter-over-quarter to $274B.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.